Table 1.
Group A (n=16 230) | Group B (n=7973) | P Value | |
---|---|---|---|
Age at GE, y | 71.3±11.6 | 68.8±12.5 | <0.001 |
Male sex, % | 70.9 | 76.9 | <0.001 |
Time of first battery implant, y | 5.4±1.3 | 5.3±1.2 | <0.001 |
Device type, % | <0.001 | ||
Single‐chamber ICD | 21.4 | 25.5 | |
Dual‐chamber ICD | 34.0 | 37.4 | |
Biventricular ICD | 44.6 | 37.1 | |
Tachytherapy device programming, % | <0.001 | ||
1 zone | 27.7 | 20.6 | |
2 zones | 51.5 | 53.4 | |
3 zones | 20.8 | 26.0 | |
VT dectection rate, bpm | 174±14 | 172±16 | <0.001 |
VF detection rate, bpm | 202±17 | 203±18 | <0.001 |
Afib burden >5%*, % | 24.5 | 31.9 | <0.001 |
RV pacing >5%, % | 42.9 | 47.0 | <0.001 |
LV pacing >95%*, % | 75.9 | 61.8 | <0.001 |
DFT performed at GE, % | 69.7 | 68.3 | 0.025 |
Afib indicates atrial fibrillation; bpm, beats per minute; DFT, defibrillation threshold testing; GE, generator exchange; ICD, implantable cardioverter‐defibrillator; LV, left ventricle; RV, right ventricle; VF, ventricular fibrillation; VT, ventricular tachycardia.
Among patients with atrial leads.
Among patients with cardiac resynchronization devices.